DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Salloway S, Sperling R, Gilman S , et al; Bapineuzumab 201 Clinical Trial Investigators.
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease.
Neurology 2009;
73 (24) 2061-2070
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.